New version MIR 7.3.1: More Safety, More Efficiency
On 5 May 2025 the European Commission published the updated version of the MIR form (v7.3.1), used by manufacturers to...
On 5 May 2025 the European Commission published the updated version of the MIR form (v7.3.1), used by manufacturers to...
In the current health digitalisation context, many app developers and companies of the healthcare sector ask themselves if their software...
Human medicinal products The importance of readability in package information leaflets and drugs’ packs is a topic that is becoming...
Cosmetic labelling will be the subject of growing controls by competent authorities. The growing attention of the European Union toward...
Statistics has a central role in the post-market surveillance and in the evaluation of medical device safety. After being placed...
Companies distributing Medical Surgical Aids (Presidi Medico-Chirurgici, PMCs) have been facing for a long time a significant change in regulations:...
According to the definition of Legislative Decree 169/2004, food supplements are “foodstuffs intended to complete ordinary diet and constituting a concentrated source...
The responsibilities and obligations of MA holders of human medicines are not limited to the marketing authorisation; on the contrary,...
Data mining is a set of advanced techniques and methods used to analyse huge amounts of data, with the aim...
Legislative Decree 4 September 2024, no. 138, adopting Directive (EU) 2022/2555 (NIS 2), introduces important obligations on the subject of...
Headquarter
Legal Office
Sede di Milano
© 2021 Di Renzo® s.r.l.
Sede legale: Viale Manzoni 59 – 00185 Roma
Sede operativa: Via dell’Arco di Travertino 11 – 00178 Roma
+39 0677209020 - P. Iva 07227271009 - Cookies Policy - Trattamento dei dati
© Copyright 2025 Di Renzo Regulatory Affairs. All Rights Reserved by Di Renzo Regulatory Affairs